There have been no biopharma initial public offerings in the US since 12 January while the industry’s valuations have plummeted by double digits since the start of 2022. Nevertheless, venture capital investment continues at a fast pace and there have been some follow-on public offerings.

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced July-August 2015.